These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 19877179)

  • 21. Differential diagnosis of cholangiocarcinoma and IgG4-related sclerosing cholangitis by fluorescence in situ hybridization using transpapillary forceps biopsy specimens.
    Kato A; Naitoh I; Miyabe K; Hayashi K; Kondo H; Yoshida M; Kato H; Kuno T; Takahashi S; Joh T
    J Hepatobiliary Pancreat Sci; 2018 Mar; 25(3):188-194. PubMed ID: 29532638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suspicious brush cytology is an indication for liver transplantation evaluation in primary sclerosing cholangitis.
    Boyd S; Vannas M; Jokelainen K; Isoniemi H; Mäkisalo H; Färkkilä MA; Arola J
    World J Gastroenterol; 2017 Sep; 23(33):6147-6154. PubMed ID: 28970730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An assessment of chromosomal alterations detected by fluorescence in situ hybridization and p16 expression in sporadic and primary sclerosing cholangitis-associated cholangiocarcinomas.
    DeHaan RD; Kipp BR; Smyrk TC; Abraham SC; Roberts LR; Halling KC
    Hum Pathol; 2007 Mar; 38(3):491-9. PubMed ID: 17239935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surveillance of primary sclerosing cholangitis with ERC and brush cytology: risk factors for cholangiocarcinoma.
    Boyd S; Mustonen H; Tenca A; Jokelainen K; Arola J; Färkkilä MA
    Scand J Gastroenterol; 2017 Feb; 52(2):242-249. PubMed ID: 27806633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Many patients with primary sclerosing cholangitis and increased serum levels of carbohydrate antigen 19-9 do not have cholangiocarcinoma.
    Sinakos E; Saenger AK; Keach J; Kim WR; Lindor KD
    Clin Gastroenterol Hepatol; 2011 May; 9(5):434-9.e1. PubMed ID: 21334457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A multivariable model using advanced cytologic methods for the evaluation of indeterminate pancreatobiliary strictures.
    Fritcher EG; Kipp BR; Halling KC; Oberg TN; Bryant SC; Tarrell RF; Gores GJ; Levy MJ; Clayton AC; Sebo TJ; Roberts LR
    Gastroenterology; 2009 Jun; 136(7):2180-6. PubMed ID: 19232347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcome and prognostic factors of 391 Japanese patients with primary sclerosing cholangitis.
    Tanaka A; Takamori Y; Toda G; Ohnishi S; Takikawa H
    Liver Int; 2008 Aug; 28(7):983-9. PubMed ID: 18397233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biliary dysplasia in primary sclerosing cholangitis harbors cytogenetic abnormalities similar to cholangiocarcinoma.
    Kerr SE; Barr Fritcher EG; Campion MB; Voss JS; Kipp BR; Halling KC; Lewis JT
    Hum Pathol; 2014 Sep; 45(9):1797-804. PubMed ID: 25027853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Magnetic resonance cholangiopancreatography in the diagnosis of primary sclerosing cholangitis.
    Weber C; Kuhlencordt R; Grotelueschen R; Wedegaertner U; Ang TL; Adam G; Soehendra N; Seitz U
    Endoscopy; 2008 Sep; 40(9):739-45. PubMed ID: 18698533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathogenesis, diagnosis and treatment of premalignant and malignant stages of cholangiocarcinoma in primary sclerosing cholangitis.
    Grimsrud MM; Folseraas T
    Liver Int; 2019 Dec; 39(12):2230-2237. PubMed ID: 31216595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver transplantation for cholangiocarcinoma: selection is essential for acceptable results.
    Friman S; Foss A; Isoniemi H; Olausson M; Höckerstedt K; Yamamoto S; Karlsen TH; Rizell M; Ericzon BG
    Scand J Gastroenterol; 2011 Mar; 46(3):370-5. PubMed ID: 21073376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monitoring dominant strictures in primary sclerosing cholangitis with brush cytology and FDG-PET.
    Sangfelt P; Sundin A; Wanders A; Rasmussen I; Karlson BM; Bergquist A; Rorsman F
    J Hepatol; 2014 Dec; 61(6):1352-7. PubMed ID: 25111173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of primary sclerosing cholangitis.
    Björnsson E
    Minerva Gastroenterol Dietol; 2009 Jun; 55(2):163-72. PubMed ID: 19305376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cholangiographic findings in deteriorating primary sclerosing cholangitis.
    Van Laethem JL; Devière J; Bourgeois N; Love J; Gelin M; Cremer M; Adler M
    Endoscopy; 1995 Mar; 27(3):223-8. PubMed ID: 7664699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biliary dysplasia in patients with primary sclerosing cholangitis: additional value of DNA ploidity.
    Halme L; Arola J; Numminen K; Krogerus L; Mäkisalo H; Färkkilä M
    Liver Int; 2012 May; 32(5):783-9. PubMed ID: 22098817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma.
    Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
    Am J Surg Pathol; 2010 Jan; 34(1):27-34. PubMed ID: 19898228
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characteristics and clinical course of primary sclerosing cholangitis in France: a prospective cohort study.
    Garioud A; Seksik P; Chrétien Y; Corphechot C; Poupon R; Poupon RE; Chazouillères O
    Eur J Gastroenterol Hepatol; 2010 Jul; 22(7):842-7. PubMed ID: 19779305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peroral cholangioscopy facilitates targeted tissue acquisition in patients with suspected cholangiocarcinoma.
    Liu R; Cox Rn K; Siddiqui A; Feurer M; Baron T; Adler DG
    Minerva Gastroenterol Dietol; 2014 Jun; 60(2):127-33. PubMed ID: 24780947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outruling cholangiocarcinoma in patients with primary sclerosing cholangitis wait-listed for liver transplantation: A report on the Irish national experience.
    Duggan WP; Brosnan C; Christodoulides N; Nolan N; Kambakamba P; Gallagher TK
    Surgeon; 2023 Apr; 21(2):e83-e88. PubMed ID: 35680491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis.
    Charatcharoenwitthaya P; Enders FB; Halling KC; Lindor KD
    Hepatology; 2008 Oct; 48(4):1106-17. PubMed ID: 18785620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.